Events & Presentations Upcoming Events No upcoming events at this time Past Events SVB Securities Virtual Global Biopharma Conference 2023 Feb 16, 2023 at 2:20 PM EST Click here for webcast Investor Presentations ARS Corporate Presentation ARS Corporate Presentation 3.6 MB Scientific Publications JACI 2023 Single and Repeat Dose Publication Pharmacokinetics/pharmacodynamics of epinephrine after single and repeat admini… Scientific Presentations ACAAI 2022 Poster 236 Pharmacokinetics and Pharmacodynamics of ARS-1 (neffy® Nasal Spray) and Manual Intramuscular Injection in Subjects With/Without Allergic Rhinitis 1.5 MB AAAAI 2022 Poster 007 Self-Administration of Intranasal Epinephrine (neffy ) Using the Aptar Unit Dose System Compared to EpiPen and Symjepi 637.1 KB ACAAI 2022 Poster 006 Time Before Use of Epinephrine Injectable Devices and Triggers Driving Use: A Patient/Caregiver Survey 1.3 MB AAAAI 2020 Poster 022 Learning from Epinephrine Treatment Characteristics Among Patients with Severe Allergic Reactions 787.7 KB ACAAI 2022 Poster 237 ARS-1 (neffy® Nasal Spray) and Intramuscular Injection: Pharmacokinetic/Pharmacodynamic Differences and Differential Affinities for Adrenergic Receptors 3.4 MB AAAAI 2022 Poster 008 Comparison of Pharmacokinetic Parameters and Intra-Blood Vessel Injection Rates Between Manual Intramuscular Injection and Epinephrine Auto-Injectors 333.1 KB ACAAI 2022 Poster 008 Epinephrine Via Needle-Free Device Would Be Administered Faster After Symptoms: Results of a Patient/Caregiver Survey 1.1 MB Pagination First page « first Previous page ‹ previous Page 1 Current page 2
Investor Presentations ARS Corporate Presentation ARS Corporate Presentation 3.6 MB Scientific Publications JACI 2023 Single and Repeat Dose Publication Pharmacokinetics/pharmacodynamics of epinephrine after single and repeat admini… Scientific Presentations ACAAI 2022 Poster 236 Pharmacokinetics and Pharmacodynamics of ARS-1 (neffy® Nasal Spray) and Manual Intramuscular Injection in Subjects With/Without Allergic Rhinitis 1.5 MB AAAAI 2022 Poster 007 Self-Administration of Intranasal Epinephrine (neffy ) Using the Aptar Unit Dose System Compared to EpiPen and Symjepi 637.1 KB ACAAI 2022 Poster 006 Time Before Use of Epinephrine Injectable Devices and Triggers Driving Use: A Patient/Caregiver Survey 1.3 MB AAAAI 2020 Poster 022 Learning from Epinephrine Treatment Characteristics Among Patients with Severe Allergic Reactions 787.7 KB ACAAI 2022 Poster 237 ARS-1 (neffy® Nasal Spray) and Intramuscular Injection: Pharmacokinetic/Pharmacodynamic Differences and Differential Affinities for Adrenergic Receptors 3.4 MB AAAAI 2022 Poster 008 Comparison of Pharmacokinetic Parameters and Intra-Blood Vessel Injection Rates Between Manual Intramuscular Injection and Epinephrine Auto-Injectors 333.1 KB ACAAI 2022 Poster 008 Epinephrine Via Needle-Free Device Would Be Administered Faster After Symptoms: Results of a Patient/Caregiver Survey 1.1 MB Pagination First page « first Previous page ‹ previous Page 1 Current page 2
Pharmacokinetics and Pharmacodynamics of ARS-1 (neffy® Nasal Spray) and Manual Intramuscular Injection in Subjects With/Without Allergic Rhinitis 1.5 MB
Self-Administration of Intranasal Epinephrine (neffy ) Using the Aptar Unit Dose System Compared to EpiPen and Symjepi 637.1 KB
Time Before Use of Epinephrine Injectable Devices and Triggers Driving Use: A Patient/Caregiver Survey 1.3 MB
Learning from Epinephrine Treatment Characteristics Among Patients with Severe Allergic Reactions 787.7 KB
ARS-1 (neffy® Nasal Spray) and Intramuscular Injection: Pharmacokinetic/Pharmacodynamic Differences and Differential Affinities for Adrenergic Receptors 3.4 MB
Comparison of Pharmacokinetic Parameters and Intra-Blood Vessel Injection Rates Between Manual Intramuscular Injection and Epinephrine Auto-Injectors 333.1 KB
Epinephrine Via Needle-Free Device Would Be Administered Faster After Symptoms: Results of a Patient/Caregiver Survey 1.1 MB
